Top compounds associated with response to CLDN5


Feature Type Standardized
Nominal ANOVA
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.11 0.002
mRNA AZD7762 GDSC1000 pan-cancer AAC -0.097 0.002
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.1 0.002
mRNA KIN001-236 GDSC1000 pan-cancer AAC 0.099 0.002
mRNA BMS-345541 GDSC1000 pan-cancer AAC 0.092 0.003
mRNA indisulam CTRPv2 pan-cancer AAC 0.094 0.003
mRNA KPT185 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.1 0.003
mRNA PX-12 CTRPv2 pan-cancer AAC 0.084 0.003
mRNA lapatinib gCSI pan-cancer AAC -0.16 0.003
Download CSV